Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mexiletine for the Treatment of Muscle Cramps in ALS

This study has been completed.
Sponsor:
Collaborators:
University of California, Davis
ALS Association
Information provided by (Responsible Party):
Bjorn Oskarsson, MD, University of California, Davis
ClinicalTrials.gov Identifier:
NCT01811355
First received: March 6, 2013
Last updated: May 10, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2016
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)